EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 18, Issue 1
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Sourcing Reference Products for Biosimilar Development – to finish
Editorial Archive

Sourcing Reference Products for Biosimilar Development – to finish

The prescription of biological products is becoming increasingly common, and these products are often the only treatment available for certain diseases. In this artic...
11 October 2016 Editorial Archive | Logistics V8 I5
Continue Reading →
T-peak to T-end: Additional Potential Biomarkers of Interest in the Field of Cardiac Safety
Editorial Archive

T-peak to T-end: Additional Potential Biomarkers of Interest in the Field of Cardiac Safety

Timothy Callahan, PhD, Chief Scientific Officer at Biomedical Systems, writes a paper on how regulatory interest and then, by necessity, drug development and scientif...
11 October 2016 Editorial Archive | Special Features V8 I5
Continue Reading →
Untapped Opportunities in Southeast Asia
Editorial Archive

Untapped Opportunities in Southeast Asia

Sue Lee of World Courier provides a detailed analysis of Southeast Asia, a growing pharmaceutical market with an increase in clinical trials in recent years. Starting...
11 October 2016 Editorial Archive | Watch Pages V8 I5
Continue Reading →
Use of Concentration-effect Modelling for Cardiac Safety ECG Assessments
Editorial Archive

Use of Concentration-effect Modelling for Cardiac Safety ECG Assessments

Robert B. Kleiman, MD, Chief Medical Officer at ERT, shares his knowledge of concentration-effect modelling (CEM), a method of data evaluation which is also commonly ...
11 October 2016 Editorial Archive | Special Features V8 I5
Continue Reading →
Non-alcoholic Steatohepatitis: The Hidden Pandemic
Editorial Archive

Non-alcoholic Steatohepatitis: The Hidden Pandemic

Obesity has become a major public health concern worldwide. Obesity is linked to the accumulation of fat in the liver, which can be associated with hepatic inflammati...
11 October 2016 Editorial Archive | Watch Pages V8 I5
Continue Reading →
Off-target Blood Pressure Effects in Biopharmaceutical Therapeutic Treatment Development: Points to Consider
Editorial Archive

Off-target Blood Pressure Effects in Biopharmaceutical Therapeutic Treatment Development: Points to Consider

In this Special Feature column, Jeff Heilbraun, MS, Senior Director of Strategic Development at Bioclinica Cardiac Safety observes that, over the past five years, the...
11 October 2016 Editorial Archive | Special Features V8 I5
Continue Reading →
With the Multitude of Benefits that ePRO Provides, Why are Clinical Trials Still Using Paper?
Editorial Archive

With the Multitude of Benefits that ePRO Provides, Why are Clinical Trials Still Using Paper?

Essential Tips for Making the Switch The electronic capture of patient-reported outcomes (PROs) and clinical outcome assessments (COAs) has proven to be a valuable me...
11 October 2016 Editorial Archive | Technology V8 I5
Continue Reading →
FDA Debates Drug Approval for Rare Degenerative Disease in Boys
Editorial Archive

FDA Debates Drug Approval for Rare Degenerative Disease in Boys

In this article, Molly Fellin Spence, writer and editor for Thomson Reuters, explains that the US Food and Drug Administration (FDA) has twice delayed a final decisio...
16 August 2016 Editorial Archive | Volume 8 Issue 4
Continue Reading →
Advances in Preclinical Imaging Provide New Insights for Oncology Research
Editorial Archive

Advances in Preclinical Imaging Provide New Insights for Oncology Research

The tried and trusted imaging modalities in the preclinical researcher’s toolkit have undergone an evolution over recent years and a number of multi-modal techniques ...
15 April 2016 Editorial Archive | Special Features V8 I2 | Volume 8 Issue 2
Continue Reading →
Statistically Speaking – Why a Hybrid of Centralised
Editorial Archive

Statistically Speaking – Why a Hybrid of Centralised

Statistical Monitoring and Key Risk Indicators could be the Answer for Risk-based Monitoring The industry is at a crossroads when it comes to data-driven monitoring p...
15 April 2016 Editorial Archive | Special Features V8 I2 | Volume 8 Issue 2
Continue Reading →
Catalyst: 12th January 2026
Quotient

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte